Compile Data Set for Download or QSAR
Report error Found 73 Enz. Inhib. hit(s) with all data for entry = 11114
TargetAdenosine receptor A1(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479527(3-amino-5-(4-fluorophenyl)-6-(3- methyl-3H-benzo[d...)
Affinity DataIC50: 0.900nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479512(3-amino-N-(2,6-difluorobenzyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 1nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479372(3-amino-N-(2,6-difluorobenzyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 1.40nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479530((R)-3-amino-6-(3-methylimidazo[1,2-a] pyridin-6-yl...)
Affinity DataIC50: 1.40nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479535((R)-3-amino-6-(3-methylimidazo[1,2-a] pyridin-6-yl...)
Affinity DataIC50: 1.70nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479372(3-amino-N-(2,6-difluorobenzyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 1.90nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479533(US10898481, Compound 134 | US10898481, Compound 13...)
Affinity DataIC50: 2nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479519(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(3-met...)
Affinity DataIC50: 2.10nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479537((R)-3-amino-5-(4-fluorophenyl)-6-(3- methylimidazo...)
Affinity DataIC50: 2.20nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479509(3-amino-N-(2,6-difluorobenzyl)-5- (4-fluorophenyl)...)
Affinity DataIC50: 2.30nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479525(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(3-met...)
Affinity DataIC50: 2.40nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479522(N-((3-amino-5-(4-fluorophenyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 2.40nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479516(3-amino-6-(1H-benzo[d]imidazol-5-yl)- N-((3-fluoro...)
Affinity DataIC50: 2.60nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479532(3-amino-N-isopropyl-6-(3-methyl- imidazo[1,2-a]pyr...)
Affinity DataIC50: 2.70nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479507(3-amino-6-(1-methyl-6-oxo-1,6- dihydropyridin-3-yl...)
Affinity DataIC50: 2.90nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479528(3-amino-6-(3-methylimidazo[1,2-a] pyridin-6-yl)-N-...)
Affinity DataIC50: 2.90nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479397(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(1-met...)
Affinity DataIC50: 3.10nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479531((S)-3-amino-6-(3-methylimidazo[1,2-a] pyridin-6-yl...)
Affinity DataIC50: 3.10nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479517(3-amino-N-((6-aminopyridin-2-yl) methyl)-6-(imidaz...)
Affinity DataIC50: 3.10nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479540((S)-3-amino-N-(1-methoxypropan-2-yl)- 6-(3-methyli...)
Affinity DataIC50: 3.15nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479511(3-amino-N-(2,6-difluorobenzyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 3.20nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479514(3-amino-N-(2,6-difluorobenzyl)-6-(1- (2-hydroxyeth...)
Affinity DataIC50: 3.30nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479506(3-amino-6-(1-methyl-6-oxo-1,6- dihydropyridin-3-yl...)
Affinity DataIC50: 3.5nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479507(3-amino-6-(1-methyl-6-oxo-1,6- dihydropyridin-3-yl...)
Affinity DataIC50: 3.5nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479510(6-([1,2,4]triazolo[4,3-a]pyridin-6-yl)-3- amino-N-...)
Affinity DataIC50: 3.70nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479528(3-amino-6-(3-methylimidazo[1,2-a] pyridin-6-yl)-N-...)
Affinity DataIC50: 3.70nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479536((S)-3-amino-6-(3-methylimidazo[1,2-a] pyridin-6-yl...)
Affinity DataIC50: 3.90nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479491(3-amino-N-((6-(dimethylamino)pyridin- 2-yl)methyl)...)
Affinity DataIC50: 3.90nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479538((S)-3-amino-5-(4-fluorophenyl)-6-(3- methylimidazo...)
Affinity DataIC50: 5.20nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM592143(US11571420, Compound 40)
Affinity DataIC50: 5.20nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479518(3-amino-N-((6-amino-3-fluoropyridin- 2-yl)methyl)-...)
Affinity DataIC50: 5.30nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479533(US10898481, Compound 134 | US10898481, Compound 13...)
Affinity DataIC50: 5.5nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479525(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(3-met...)
Affinity DataIC50: 5.60nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479539(3-amino-N-(2-methoxyethyl)-6-(3- methylimidazo[1,2...)
Affinity DataIC50: 5.60nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479526(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(imida...)
Affinity DataIC50: 6.20nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479527(3-amino-5-(4-fluorophenyl)-6-(3- methyl-3H-benzo[d...)
Affinity DataIC50: 6.90nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479520(3-amino-6-(2,6-dimethylpyridin-4-yl)- N-(2-methoxy...)
Affinity DataIC50: 7.90nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479524(6-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-3- amino-N-...)
Affinity DataIC50: 8.40nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479541(3-amino-N-cyclobutyl-6-(3- methylimidazo[1,2-a]pyr...)
Affinity DataIC50: 9.10nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479523(3-amino-N-(1-(2,6-difluorophenyl)-2- hydroxyethyl)...)
Affinity DataIC50: 9.30nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479523(3-amino-N-(1-(2,6-difluorophenyl)-2- hydroxyethyl)...)
Affinity DataIC50: 10nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479508(3-amino-N-((6-aminopyridin-2-yl) methyl)-6-(1-meth...)
Affinity DataIC50: 11nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479521(3-amino-6-(2,6-dimethylpyridin-4-yl)- 5-(4-fluorop...)
Affinity DataIC50: 13nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479491(3-amino-N-((6-(dimethylamino)pyridin- 2-yl)methyl)...)
Affinity DataIC50: 15nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479372(3-amino-N-(2,6-difluorobenzyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 16nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479522(N-((3-amino-5-(4-fluorophenyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 17nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479537((R)-3-amino-5-(4-fluorophenyl)-6-(3- methylimidazo...)
Affinity DataIC50: 17nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479515(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(imida...)
Affinity DataIC50: 21nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479521(3-amino-6-(2,6-dimethylpyridin-4-yl)- 5-(4-fluorop...)
Affinity DataIC50: 30nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM479526(3-amino-N-((3-fluoropyridin-2-yl) methyl)-6-(imida...)
Affinity DataIC50: 49nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 73 total ) | Next | Last >>
Jump to: